| 000 | 01847 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514205715.0 | ||
| 264 | 0 | _c20050303 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 024 | 7 |
_a10.1182/blood-2004-06-2501 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRivera, Victor M | |
| 245 | 0 | 0 |
_aLong-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. _h[electronic resource] |
| 260 |
_bBlood _cFeb 2005 |
||
| 300 |
_a1424-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Validation Study | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCytomegalovirus _xgenetics |
| 650 | 0 | 4 |
_aDependovirus _xclassification |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aErythropoietin _xbiosynthesis |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 |
_aGraft Rejection _xetiology |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aMacaca mulatta |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aSerotyping |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 |
_aSkin Transplantation _ximmunology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aGao, Guang-ping | |
| 700 | 1 | _aGrant, Rebecca L | |
| 700 | 1 | _aSchnell, Michael A | |
| 700 | 1 | _aZoltick, Philip W | |
| 700 | 1 | _aRozamus, Leonard W | |
| 700 | 1 | _aClackson, Tim | |
| 700 | 1 | _aWilson, James M | |
| 773 | 0 |
_tBlood _gvol. 105 _gno. 4 _gp. 1424-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2004-06-2501 _zAvailable from publisher's website |
| 999 |
_c15196507 _d15196507 |
||